Navigation Links
DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation
Date:12/15/2008

EL SEGUNDO, Calif., Dec. 15 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), today announced that it is working with the U.S. Department of Health and Human Services, Office of Inspector General ("OIG") to respond to a subpoena request for documents issued in connection with the civil investigation by the Department of Justice and the U.S. Attorney's Office for the Northern District of Georgia previously reported in the Company's Quarterly Report on 10-Q for the period ended September 30, 2008. The subpoena was sent from the OIG's office in Atlanta, Georgia and was received by the Company on December 12, 2008. The subpoena applies to the Company and its subsidiaries and covers a time period from January 1, 2003 to the present. In response to the subpoena, DaVita will produce a wide range of documents relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlicit, and Epogen. The Company intends to meet with representatives of the government to discuss the scope of the subpoena and the production of responsive documents.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

To the Company's knowledge, no proceedings have been initiated against the Company at this time, although the Company cannot predict whether or when proceedings might be initiated. The Company intends to cooperate with the government's investigation.

"DaVita has been involved in several investigations over the last 9 years, including some covering issues that are repeated in this subpoena. We respect the government's need to ensure the appropriateness of healthcare provider practices, especially during times when pharmaceutical issues involve significant expense for Medicare. We look forward to meeting with government representatives on this new investigation and once again demonstrating the strength of our clinical outcomes and the integrity and comprehensiveness of DaVita's Compliance programs," said LeAnne Zumwalt, spokesperson for DaVita.

DaVita is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita.com Receives eHealthcare Leadership Award
2. DaVita.com Launches Physician Website
3. Tour DaVita Raises More Than $400K for Kidney Disease Awareness
4. DaVita Abstracts Accepted into American Society of Nephrology Meeting
5. Modern Healthcare Names DaVita One of the Best Places to Work
6. DaVita 3rd Quarter 2008 Results
7. Spokesman at the United Nations Joins DaVita
8. Tour DaVita Rides to Improve Kidney Disease Education
9. DaVita Dietitians to Speak at the International Congress on Nutrition and Metabolism in Renal Disease in France
10. DaVita Magazine Takes Home Two Prestigious Hermes Creative Awards
11. DaVita Renal Dietitians Conduct First-Ever EYE on CKD Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: